Maryland
How Bruesewitz v. Wyeth LLC applies in Maryland: state-specific rules, key cases, and bar exam notes for Products Liability (Preemption).
Maryland follows the principles of federal preemption, particularly regarding the regulation of vaccines. Like the Bruesewitz decision, Maryland courts typically emphasize that federal law preempts state law claims when there is a regulatory regime already in place.
In Maryland, products liability claims against vaccine manufacturers are preempted if the vaccines are approved under the National Childhood Vaccine Injury Act and if the claims involve design defects that conflict with the regulations set by the FDA.
Held that the vaccine manufacturer was shielded from liability under state tort law due to federal preemption by the National Childhood Vaccine Injury Act.
Ruled that federal law preempted a design defect claim against a manufacturer of a vaccine, reinforcing the standards established in Bruesewitz.
Affirmed that state law claims are preempted when they impose requirements different from federal regulations in vaccine cases.
Maryland courts generally align with the federal standard articulated in Bruesewitz, emphasizing that the federal regulatory framework for vaccines is comprehensive and that state law cannot impose additional requirements. This consistency reinforces the protective measures for vaccine manufacturers under federal law.
Understanding the implications of preemption in products liability cases, particularly as it relates to vaccines, is crucial for the Maryland bar exam, where products liability is often tested.